Pharmacokinetics and relative bioavailability of domestic azithromycin dispersible tablets in healthy volunteers
Chu Xiao
Abstract
Chu Xiao
Abstract
OBJECTIVE:The pharmacokinetics and bioavailabilites of domestic azithromycin dispersible tablets (tested) and imported tablets (reference) were studied.METHODS:A single dose of 500mg azithromycin was given, in a randomized,two way crossover study,in 12 healthy male volunteers.The concentrations in plasma were determined by microbiological assay.RESULTS:Both concentration time curves of domestic and imported products fitted to a two compartment open model with a first order absorption.The main pharmacokinetics parameters were as followings: t 1/2β :( 45.2 ± 10.3 )h,( 45.7 ± 9.2 )h; T max :( 1.3 ± 0.6 )h,( 2.0 ± 1.0 )h; C max :( 414.7 ± 123.8 )μg·L -1 ,( 352.5 ± 92.1 )μg·L -1 ; AUC 0→tn :( 480 4.2 ± 957.6 )μg·L -1 ·h -1 ,( 510 9.8 ± 101 0.5 )μg·L -1 ·h -1 .There are no significant difference between pharmacokinetics parmeters of two preparations ( P 0.05 ).The relative bioavailability of the domestic dispersible tablets was ( 94.7 ± 13.4 )%.CONCLUSIONS:The results of statistical analysis show that two formulations are bioeqivalent. [
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:The pharmacokinetics and bioavailabilites of domestic azithromycin dispersible tablets (tested) and imported tablets (reference) were studied.METHODS:A single dose of 500mg azithromycin was given, in a randomized,two way crossover study,in 12 healthy male volunteers.The concentrations in plasma were determined by microbiological assay.RESULTS:Both concentration time curves of domestic and imported products fitted to a two compartment open model with a first order absorption.The main pharmacokinetics parameters were as followings: t 1/2β :( 45.2 ± 10.3 )h,( 45.7 ± 9.2 )h; T max :( 1.3 ± 0.6 )h,( 2.0 ± 1.0 )h; C max :( 414.7 ± 123.8 )μg·L -1 ,( 352.5 ± 92.1 )μg·L -1 ; AUC 0→tn :( 480 4.2 ± 957.6 )μg·L -1 ·h -1 ,( 510 9.8 ± 101 0.5 )μg·L -1 ·h -1 .There are no significant difference between pharmacokinetics parmeters of two preparations ( P 0.05 ).The relative bioavailability of the domestic dispersible tablets was ( 94.7 ± 13.4 )%.CONCLUSIONS:The results of statistical analysis show that two formulations are bioeqivalent. [
Key concepts: Pharmacokinetics, Bioavailability, Azithromycin, Crossover study, Bioequivalence, Absorption (acoustics), Pharmacology, Plasma concentration